ANANDA PHARMA PLC (ANANF)
Clinical trial NCT05286112 updates: 1. completion date: 2025-03-21 → 2026-02-28 2. primary completion date: 2025-03-21 → 2026-02-28
Clinical trial NCT05286112 updates: 1. completion date: 2025-03-21 → 2026-02-28 2. primary completion date: 2025-03-21 → 2026-02-28
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical